Heart Health Varies With Race Among Sexual-Minority Females
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 1, 2024 -- For sexual-minority (SM) females, cardiovascular health (CVH) varies across race and ethnicity, according to a study published online May 1 in JAMA Network Open.
Nicole Rosendale, M.D., from the University of California San Francisco, and colleagues used the American Heart Association Life's Essential 8 measure to examine differences in CVH at the intersection of race, ethnicity, and sexual identity. The cross-sectional study used data from the National Health and Nutrition Examination Survey from 2007 to 2016. The primary outcome was overall CVH score, which is the unweighted mean of eight CVH metrics.
The sample included 12,180 adults. The researchers found that Black, Hispanic, and White SM female adults had lower overall CVH scores compared with their heterosexual counterparts in analyses adjusted for age, survey year, and socioeconomic status (β = −3.2, −5.9, -and −3.3, respectively). For female adults of other race and ethnicity and for SM male adults of any race and ethnicity, there were no statistically significant differences seen compared with heterosexual counterparts.
"This study highlights the importance of incorporating intersectionality into CVH health equity studies and interventions," the authors write. "Tailored interventions to improve the CVH of SM individuals, particularly Black and Hispanic SM female individuals, are needed."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.